Production and discovery of novel recombinant adeno-associated viral vectors
| dc.contributor.author | Mueller, Christian | |
| dc.contributor.author | Zhong, Li | |
| dc.contributor.author | Ratner, Dmitry | |
| dc.contributor.author | Sena-Esteves, Miguel | |
| dc.contributor.author | Gao, Guangping | |
| dc.date | 2022-08-11T08:10:14.000 | |
| dc.date.accessioned | 2022-08-23T17:00:46Z | |
| dc.date.available | 2022-08-23T17:00:46Z | |
| dc.date.issued | 2012-08-01 | |
| dc.date.submitted | 2012-08-14 | |
| dc.identifier.citation | <p>Curr Protoc Microbiol. 2012 Aug;Chapter 14:Unit14D.1. DOI: 10.1002/9780471729259.mc14d01s26</p> | |
| dc.identifier.issn | 1934-8533 | |
| dc.identifier.doi | 10.1002/9780471729259.mc14d01s26 | |
| dc.identifier.pmid | 22875565 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/43861 | |
| dc.description.abstract | In this unit, we describe the detailed procedure for a three-plasmid transfection method for rAAV production, and discuss its advantages, limitations, and troubleshooting techniques. We further discuss the rAAV purification process using CsCl gradients, as well as subsequent quality control methods using SDS-PAGE and real-time PCR to assess vector purity, packaging efficiency, and viral titer. Finally, we elaborate on a PCR-based strategy that can be used to discover novel AAV capsid sequences from primate tissue, which can be used to develop newer-generation rAAVs with a greater diversity of tissue tropism for clinical gene therapy. Curr. Protoc. Microbiol. 26:14D.1.1-14D.1.21. © 2012 by John Wiley & Sons, Inc. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22875565&dopt=Abstract">Link to article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1002/9780471729259.mc14d01s26 | |
| dc.subject | Dependovirus | |
| dc.subject | Genetic Vectors | |
| dc.subject | Gene Therapy | |
| dc.subject | Allergy and Immunology | |
| dc.subject | Biomedical Engineering and Bioengineering | |
| dc.subject | Genetics and Genomics | |
| dc.subject | Medical Genetics | |
| dc.subject | Pediatrics | |
| dc.subject | Respiratory Tract Diseases | |
| dc.title | Production and discovery of novel recombinant adeno-associated viral vectors | |
| dc.type | Book Chapter | |
| dc.source.booktitle | Current Protocols in Microbiology | |
| dc.source.volume | Chapter 14 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/peds_pulmonary/72 | |
| dc.identifier.contextkey | 3212184 | |
| html.description.abstract | <p>In this unit, we describe the detailed procedure for a three-plasmid transfection method for rAAV production, and discuss its advantages, limitations, and troubleshooting techniques. We further discuss the rAAV purification process using CsCl gradients, as well as subsequent quality control methods using SDS-PAGE and real-time PCR to assess vector purity, packaging efficiency, and viral titer. Finally, we elaborate on a PCR-based strategy that can be used to discover novel AAV capsid sequences from primate tissue, which can be used to develop newer-generation rAAVs with a greater diversity of tissue tropism for clinical gene therapy. Curr. Protoc. Microbiol. 26:14D.1.1-14D.1.21. © 2012 by John Wiley & Sons, Inc.</p> | |
| dc.identifier.submissionpath | peds_pulmonary/72 | |
| dc.contributor.department | Department of Microbiology and Physiology Systems | |
| dc.contributor.department | Department of Neurology | |
| dc.contributor.department | Department of Medicine | |
| dc.contributor.department | Department of Pediatrics | |
| dc.contributor.department | Gene Therapy Center | |
| dc.source.pages | Unit14D.1 |